Savara, Inc. · NASDAQ:SVRA
Lowrance David L sold 394,528 Savara, Inc. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 22, 2026
On Jun 22, 2026, Lowrance David L (Chief Financial Officer) sold 394,528 Savara, Inc. shares at US$5.68 for US$2.24M, leaving 536,032 shares. Filed Jun 22, 2026 (Form 4).
- Sold
- 394,528 shares
- Price
- US$5.68
- Value
- US$2.24M
- Holding after
- 536,032 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Option exercise | 75,000 | US$1.59 | 611,032 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 21,682 | US$5.50 | 589,350 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 129,350 | US$1.23 | 718,700 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 28,928 | US$5.50 | 689,772 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 56,937 | US$1.11 | 746,709 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 11,491 | US$5.50 | 735,218 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 218,750 | US$1.51 | 953,968 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 60,057 | US$5.50 | 893,911 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 12,500 | US$4.45 | 906,411 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 10,114 | US$5.50 | 896,297 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 87,650 | US$3.35 | 983,947 | Direct |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 53,387 | US$5.50 | 930,560 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 394,528 | US$5.68 | 536,032 | Direct |
Source
Related
- Savara, Inc.
- Lowrance David L
- Savara, Inc. shareholders
- Form 4 · Parker Braden C. · Sep 25, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Form 4 · Lutz Robert Matthew · Jul 24, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Feb 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 17, 2026